Quick search:
Content Ideas
| Result | Content Idea | Research |
|---|---|---|
| Result | Content Idea | Research |
| 1 | Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center | NEJM |
|
| 2 | Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 |
|
| 3 | Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Response from the Manufacturer | NEJM |
|
| 4 | Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination |
|
| 5 | Covid-19 and the Investigator Pipeline |
|
| 6 | Orf | NEJM |
|
| 7 | Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination |
|
| 8 | SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia |
|
| 9 | BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers | NEJM |
|
| 10 | Stalking the Diagnosis |
|
| 11 | Preparing for the Future — Nanobodies for Covid-19? | NEJM |
|
| 12 | New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder |
|
| 13 | Leveraging Open Science to Accelerate Research |
|
| 14 | Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization | NEJM |
|
| 15 | Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2 |
|
| 16 | Health Care Worker Strikes and the Covid Pandemic | NEJM |
|
| 17 | SARS-CoV-2 Antibody Response in Persons with Past Natural Infection | NEJM |
|
| 18 | Beyond the Rubble of Lake Street — Minds in Crisis in a City in Crisis | NEJM |
|
| 19 | Obesity, Immunity, and Cancer |
|
| 20 | Race, Policing, and History — Remembering the Freedom House Ambulance Service | NEJM |
|
| 21 | Vancomycin Infusion Reaction — Moving beyond “Red Man Syndrome” | NEJM |
|
| 22 | SARS-CoV-2 Infection after Vaccination in Health Care Workers in California | NEJM |
|
| 23 | New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications | NEJM |
|
| 24 | Addressing Vaccine Hesitancy in BIPOC Communities — Toward Trustworthiness, Partnership, and Reciprocity |
|
| 25 | Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351) | NEJM |
|
| 26 | New England Journal of Medicine Includes Dallas Hospital Employees in Data in Recent Article |
|
| 27 | Emerging Infectious Diseases — Learning from the Past and Looking to the Future |
|
| 28 | Scaling Up Covid-19 Vaccination in Africa — Lessons from the HIV Pandemic | NEJM |
|
| 29 | “Vaccine Passport” Certification — Policy and Ethical Considerations | NEJM |
|
| 30 | New England Journal of Medicine Publishes Results of the PULSAR Phase 2 Trial of Sotatercept in Patients with Pulmonary Arterial Hypertension |
|
| 31 | Viable SARS-CoV-2 Shedding |
|
| 32 | Case 9-2021: A 16-Year-Old Boy with Headache, Abdominal Pain, and Hypertension | NEJM |
|
| 33 | Combating Anti-Asian Sentiment — A Practical Guide for Clinicians | NEJM |
|
| 34 | Advancing President Biden's Equity Agenda — Lessons from Disparities Work | NEJM |
|
| 35 | New England Journal of Medicine Publishes 24-Week Results from Phase 3 Study Evaluating RINVOQ™ (upadacitinib) in Psoriatic Arthritis |
|
| 36 | Nivolumab in Esophageal or Gastroesophageal Junction Cancer | NEJM |
|
| 37 | New England Journal of Medicine Pushes Discrimination in Medicine |
|
| 38 | Oxygenation Targets for Acute Hypoxemic Respiratory Failure | NEJM |
|
| 39 | Breathless nejm.org |
|
| 40 | Dying in a Leadership Vacuum nejm.org |
|
| 41 | Facial Masking for Covid-19 | NEJM |
|
| 42 | Hydroxychloroquine in Hospitalized Patients with Covid-19 – nejm.org |
|
| 43 | Medicine's Privileged Gatekeepers: Producing Harmful Ignorance About Racism And Health |
|
| 44 | Without Sanctuary | NEJM |
|
| 45 | Donanemab in Early Alzheimer's Disease |
|
| 46 | Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 |
|
| 47 | Medicare's New Device-Coverage Pathway — Breakthrough or Breakdown? | NEJM |
|
| 48 | Neutralizing Activity of BNT162b2-Elicited Serum |
|
| 49 | Covid-19 Vaccine Resources |
|
| 50 | Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19 |
|
| 51 | A New Vaccine to Battle Covid-19 | NEJM |
|
| 52 | A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19 |
|
| 53 | Once-Weekly Semaglutide in Adults with Overweight or Obesity | NEJM |
|
| 54 | SARS-CoV-2 Transmission among Marine Recruits during Quarantine | NEJM |
|
| 55 | Failed Assignments — Rethinking Sex Designations on Birth Certificates | NEJM |
|
| 56 | Pivotal data for lumasiran in PH1 published in NEJM |
|
| 57 | Microvascular Injury in the Brains of Patients with Covid-19 |
|
| 58 | Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine | NEJM |
|
| 59 | Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia | NEJM |
|
| 60 | Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers | NEJM |
|
| 61 | BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting | NEJM |
|
| 62 | One of Us |
|
| 63 | A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19 |
|
| 64 | The FDA and the Importance of Trust |
|
| 65 | In a First, New England Journal of Medicine Joins Never-Trumpers |
|
| 66 | A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia | NEJM |
|
| 67 | Private Equity and Physician Medical Practices — Navigating a Changing Ecosystem |
|
| 68 | The New Stability |
|
| 69 | SARS-CoV-2 Vaccination — An Ounce (Actually, Much Less) of Prevention | NEJM |
|
| 70 | Hydroxychloroquine with or without Azithromycin in Covid-19 | NEJM |
|
| 71 | Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621. |
|
| 72 | Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM |
|
| 73 | Beyond Politics — Promoting Covid-19 Vaccination in the United States | NEJM |
|
| 74 | SARS-CoV-2 in the US Military — Lessons for Civil Society |
|
| 75 | Misrepresenting Race — The Role of Medical Schools in Propagating Physician Bias |
|
| 76 | Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 |
|
| 77 | Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality |
|
| 78 | The Gift | NEJM |
|
| 79 | Corneal Bee Sting | NEJM |
|
| 80 | Covid-19 — A Reminder to Reason |
|
| 81 | Personal Protective Equipment and Covid-19 | NEJM |
|
| 82 | Can you get vaccinated if you have COVID-19? Doctors explain what to do |
|
| 83 | The Inequity of Isolation |
|
| 84 | Case 30-2020: A 54-Year-Old Man with Sudden Cardiac Arrest |
|
| 85 | Injuries from Less-Lethal Weapons during the George Floyd Protests in Minneapolis |
|
| 86 | Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms | NEJM |
|
| 87 | Telemedicine and Medical Licensure — Potential Paths for Reform | NEJM |
|
| 88 | Telephone | NEJM |
|
| 89 | Editorial The Covid-19 Vaccine-Development Multiverse |
|
| 90 | The Stress of Bayesian Medicine — Uncomfortable Uncertainty in the Face of Covid-19 |
|
| 91 | Bartonella Neuroretinitis |
|
| 92 | Experts: Outdoor Mask Mandates May Soon Be Able to Be Lifted |
|
| 93 | Penetrating Injuries from “Less Lethal” Beanbag Munitions | NEJM |
|
| 94 | New DAPA-CKD Analysis Hints at Dapagliflozin for IgA Nephropathy |
|
| 95 | Exam Requirement Lifted for Class of 2022 Due to Pandemic |
|
| 96 | Analysis of diversity at premier medical journals met with silence |
|
| 97 | Pembrolizumab Plus Lenvatinib Prolongs Survival in Renal Cell Carcinoma |
|
| 98 | Unusual treatment shows promise for children who suffer from brain tumors |
|
| 99 | New England governors are lifting pandemic mandates, but not Governor Mills |
|
| 100 | ALS 'Compassionate Use' Again Hits National Media |
|